Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | CDC25B | P30305 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.52 |
| ▸ | BCL2 | P10415 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.48 |
| ▸ | CASP1 | P29466 | 3/20 | 0.48 |
| ▸ | CASP7 | P55210 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.48 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30130196 | 1.00 | MEN1 (0.56) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL29364188 | 1.00 | MEN1 (0.56) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL29634145 | 0.97 | MEN1 (0.53) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL30458681 | 0.97 | MEN1 (0.53) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL16144676 | 0.97 | MEN1 (0.53) | MEN1KMT2ACDC25BMCL1BCL2 | |
| Ammonia Solution, Strong SCHEMBL28255083 | 0.97 | MEN1 (0.53) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL10057987 | 0.94 | MEN1 (0.50) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL236156 | 0.94 | MEN1 (0.67) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL2516264 | 0.94 | MEN1 (0.50) | MEN1KMT2ACDC25BMCL1BCL2 | |
| SCHEMBL54876 | 0.94 | MEN1 (0.50) | MEN1KMT2ACDC25BMCL1BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3864002-B1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-27 | — | — | EP | claimed |
| CN-115395000-A | Composite positive electrode material, preparation method thereof, positive plate and battery | 星恒电源股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115148982-A | Composite positive electrode material, preparation method thereof, positive plate and battery | 星恒电源股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-20220033345-A1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2022-02-03 | — | — | US | claimed |
| EP-3864002-A1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M Innovative Properties Company (US) | 2021-08-18 | — | — | EP | claimed |
| US-9944663-B2 | Process for preparing substituted pentacenes | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2018-04-17 | — | — | US | claimed |
| EP-2855010-B1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2017-12-27 | — | — | EP | claimed |
| US-20120305854-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-06 | — | — | US | claimed |
| US-8318048-B2 | Process for preparing substituted pentacenes | MERCK PATENT GMBH (DE) | 2012-11-27 | — | — | US | claimed |
| EP-2134725-B1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | MERCK PATENT GMBH (DE) | 2012-07-04 | — | — | EP | claimed |
| EP-2134725-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | Merck Patent GmbH (DE) | 2009-12-23 | — | — | EP | claimed |
| US-20090288945-A1 | Electroactivated film with electrocatalyst-enhanced carbon electrode | LUMIMOVE, INC. DBA CROSSLINK (US) | 2009-11-26 | — | — | US | claimed |
| WO-2009143314-A2 | ELECTROACTIVATED FILM WITH POLYMER GEL ELECTROLYTE | LUMIMOVE, INC., A MISSOURI CORPORATION, DBA CROSSLINK (US) | 2009-11-26 | — | — | WO | claimed |
| US-7459260-B2 | Method of reducing sensitivity of EUV photoresists to out-of-band radiation and EUV photoresists formed according to the method | INTEL CORPORATION (US) | 2008-12-02 | — | — | US | claimed |
| WO-2008128618-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | MERCK PATENT GMBH (DE) | 2008-10-30 | — | — | WO | claimed |
| US-20080246024-A1 | Method For Patterning An Organic Material To Concurrently Form An Insulator And A Semiconductor And Device Formed Thereby | KONINKLIJKE PHILIPS ELECTRONICS, N.V. (NL) | 2008-10-09 | — | — | US | claimed |
| CN-101053090-A | Method for patterning an organic material to concurrently form an insulator and a semiconductor and device formed thereby | KONINKL PHILIPS ELECTRONICS NV (NL) | 2007-10-10 | — | — | CN | claimed |
| EP-1815501-A1 | METHOD FOR PATTERNING AN ORGANIC MATERIAL TO CONCURRENTLY FORM AN INSULATOR AND A SEMICONDUCTOR AND DEVICE FORMED THEREBY | Koninklijke Philips Electronics N.V. (NL) | 2007-08-08 | — | — | EP | claimed |
| US-20060223000-A1 | Incorporating light absorbance material (functionalized anthracene, and 6,13-pentacenequinone) into extreme ultraviolet photoresist; semiconductor integrated circuits, photolithography | INTEL CORPORATION | 2006-10-05 | — | — | US | claimed |
| WO-2006048833-A1 | METHOD FOR PATTERNING AN ORGANIC MATERIAL TO CONCURRENTLY FORM AN INSULATOR AND A SEMICONDUCTOR AND DEVICE FORMED THEREBY | POLYMER VISION LIMITED (NL) | 2006-05-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120305854-A1 | PROCESS FOR PREPARING SUBSTITUTED PENTACENES | FES, PFAS, SLC46A1 | MEN1 954/4885KMT2A 2345/4885CDC25B 3169/4885 |
| US-20220033345-A1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | PARP1, ETFA, PARP2 | MEN1 2017/4885KMT2A 1722/4885CDC25B 3126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.